They system to complete this second period III study by the end of this year. When the period III is finish, MAPS will submit an application for FDA approval for MDMA therapy. They foresee FDA acceptance to come in late 2023. The moment it's approved, the DEA can have a few months to re-plan or de-agenda MDMA from its present-day Agenda-1 status. M